About 67,350 results

Sanofi/Regeneron say Dupixent skin treatment wins new regulatory approval in Europe

Mar 21st, 2023 - PARIS, March 21 (Reuters) - Healthcare companies Sanofi and Regeneron announced on Tuesday that their Dupixent product, which treats the skin disease atopic dermatitis, had won a new regulatory approval from the European Commission. The companies said the European Commission (EC) had approved Dupixent in the European Union (EU) to treat severe atopic dermatitis in children aged 6 months to 5 ye...

Cochlear, Demant contest UK regulator's Oticon deal concerns

Mar 20th, 2023 - March 20 (Reuters) - The UK’s anti-trust regulator said on Monday that hearing device maker Cochlear and Copenhagen-based Demant had denied that the Australian firm’s purchase of Demant’s hearing implants business would lead to any competition concerns. The Competition and Markets Authority (CMA) said in a statement that both Demant and Cochlear contested the regulator’s Phase 1 findings that o...

Greek regulator says station master involved in train crash had 'inadequate' training

Mar 17th, 2023 - ATHENS, March 17 (Reuters) - Greece’s rail regulator has “strong evidence” that a station master involved in a deadly train crash last month had not taken “appropriate and comprehensive” training to perform his duties, it said on Friday, detailing its probe into the country’s deadliest rail crash on record. Police detained four railway workers, including the station master on duty after the mag...

PRESS DIGEST- Financial Times - March 17

Mar 17th, 2023 - March 17 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Pay deal for NHS workers in England paves way to end strikes - ECB raises rates with signal that market unrest will direct next steps - Bentley chief says UK failing to support electric vehicle transition - CK Hutchison in deal ...

How can we tackle the biggest challenges? Ask a plant

Mar 17th, 2023 - LOS ALAMOS, N.M., March 16, 2023 — Without plants, we’d have no air to breathe or food to eat, yet plant science lingers in the shadowy wings while other fields take center stage. With the goal of shining the spotlight on plants, a new study presents the field’s top 100 most pressing questions for research to address the greatest challenges facing humanity. “The study highlights the importance ...

From PERT to AI, high-risk PE care evolves
Richard Mark Kirkner, MDedge News

Mar 16th, 2023 - In 2012, a small group of specialists, consisting of a critical care pulmonologist, cardiologist, cardiac surgeon, and vascular specialist, at Massachusetts General Hospital, Boston, met to Monday morning quarterback an acute pulmonary embolism case that didn’t go as well as they’d hoped. They came up with a concept known as the pulmonary embolism response team – PERT for short – an idea that s.

Discordant Biomarkers Foretell Prognosis in Oropharyngeal Cancer

Mar 15th, 2023 - Mismatch between the p16 protein and human papillomavirus (HPV) biomarkers can help determine prognosis in patients with oropharyngeal cancer, European researchers reported. Specifically, oropharyngeal cancer patients with discordance between the p16 (p16INK4a ) and HPV biomarker had significantly worse disease-free survival (DFS) and overall survival (OS) than double-positive patients, though ...

Bird flu associated with hundreds of seal deaths in New England in 2022, Tufts researchers find

Mar 15th, 2023 - Researchers at Cummings School of Veterinary Medicine at Tufts University found that an outbreak of highly pathogenic avian influenza (HPAI) was associated with the deaths of more than 330 New England harbor and gray seals along the North Atlantic coast in June and July 2022, and the outbreak was connected to a wave of avian influenza in birds in the region. The study was published on March 15 ...

New global ranking for life expectancy shows decades-long UK decline

Mar 15th, 2023 - A new analysis of global rankings of life expectancy over seven decades shows the UK has done worse than all G7 countries except the USA. Researchers writing in the Journal of the Royal Society of Medicine say that while UK life expectancy has increased in absolute terms over recent decades, other, similar countries are experiencing larger increases. In 1952, when Queen Elizabeth II came to the...

French strike continues to block reactor maintenance, power production - union

Mar 14th, 2023 - PARIS, March 14 (Reuters) - French power supply was reduced by 18 gigawatts (GW) at nuclear, thermal and hydropower plants on Tuesday due to the strike against the government’s planned pension overhaul, a CGT union spokesperson told Reuters. That equates to 28% of current total power production, data from grid operator RTE showed. However, France was exporting 8.7 GW to neighbours, suggesting t...

Microsoft signs licensing deal with cloud gaming provider Boosteroid

Mar 14th, 2023 - BRUSSELS, March 14 (Reuters) - Microsoft on Tuesday signed a licensing deal with Ukraine-based cloud gaming provider Boosteroid that will allow the latter’s users to stream Activision’s Call of Duty franchise, a move aimed at addressing competition concerns over its proposed acquisition of Activision. The 10-year agreement will also bring Microsoft’s Xbox PC games to Boosteroid’s cloud gaming p...

PRESS DIGEST- Financial Times - March 14

Mar 14th, 2023 - March 14 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Venture capitalists weigh SVB salvage operation - US capitalism is ‘breaking down before our eyes’, says Ken Griffin - Carl Icahn takes aim at genome sequencer Illumina over Grail deal - Volkswagen picks Canada for battery plant...

Holes in one health coverage leave vulnerable communities in global south

Mar 14th, 2023 - [Nairobi, Kenya] - A new research paper assessing the characteristics of One Health Networks (OHNs) globally reveals that investment in OHNs has not been equitably distributed around the world and that engagement across sectors and with a diverse array of stakeholders is sorely lacking. The study, recently published in The Lancet (February 2023) as part of a landmark four-paper series on One He...

Mediterranean diet cuts women’s cardiovascular disease and death risk by nearly 25%

Mar 14th, 2023 - Sticking closely to a Mediterranean diet cuts a woman’s risks of cardiovascular disease and death by nearly 25%, finds a pooled data analysis of the available evidence—the first of its kind—published online in the journal Heart. The findings prompt the researchers to call for more sex specific research to guide clinical practice in heart health. Cardiovascular disease accounts for more than a t...

Pandemic stress had a greater impact on those who were pregnant, study finds

Mar 14th, 2023 - COVID-19 related stress had a greater impact on the mental health of those who were pregnant during the pandemic, compared to those who weren't, new UNSW Sydney research has found. In a longitudinal study of 742 pregnant participants, Dr Susanne Schweizer from UNSW Science, together with colleagues in Europe and the US, collected data on mental health at multiple time points, both during and af...

Tampere University, Finnish Institute for Health and Welfare and Academy of Finland join efforts to renew European health and welfare systems

Mar 14th, 2023 - Demographic change, disruptions of the global economy and geopolitics, and the multiple effects of climate change are challenging entire societies. One sector under pressure is health and welfare. Meeting future challenges sustainably will require new solutions in social and health technologies, organisations, and policies. While health and welfare policies are decided on the national level, Eu...

Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancers

Mar 13th, 2023 - An investigational PET imaging agent -- zirconium-89 (89Zr)-deferoxamine (DFO)-girentuximab -- identified clear cell renal cell carcinoma (ccRCC) with high sensitivity and specificity, according to results from the phase III ZIRCON trial. Use of the agent achieved sensitivity and specificity rates of 85.5% (95% CI 79.8-89.8) and 87% (95% CI 78.8-92.3), respectively, reported Peter Mulders, MD, ...

Basal Cell Carcinoma: a Review
Clinical Advisor

Mar 13th, 2023 - Basal cell carcinoma is the most common type of skin cancer in the United States with an estimated 3.6 million new cases diagnosed annually.1-3 The exact number of new basal cell carcinoma cases is unclear as nonmelanoma skin cancers (most commonly basal cell carcinoma and squamous cell carcinoma) are not reported in cancer registries.2 Although basal cell carcinoma rarely leads to metastases o...

New study aims to break the taboo surrounding spirituality

Mar 13th, 2023 - Do you ever think about what happens when we die, whether we have a soul, or what the meaning of life is? This - and much more - is what new research is shedding light on. In 2021, more than 100,000 Danes were invited to participate in the largest questionnaire survey ever conducted on spiritual and existential needs. They were asked 20 questions, all related to these topics. Over 80 percent of...

Exposure to Air Pollution Linked to Risk of Long COVID in Young Adults

Mar 10th, 2023 - Long-term exposure to ambient air pollution was associated with an increased risk of long COVID among young adults, according to a Swedish population-based cohort study. For each increase in interquartile range (IQR) in exposure to particulate matter ≤2.5 μm (PM2.5) in 2019 (median annual exposure 6.39 μg/m3), the odds of developing long COVID increased by about 30%, reported Erik Melén, MD, Ph...